SARI inhibits angiogenesis and tumour growth of human colon cancer through directly targeting ceruloplasmin

BATF2 Deficiency Promotes Progression in Human Colorectal Cancer via Activation of HGF/MET Signaling: A Potential Rationale for Combining MET Inhibitors with IFNs

(2015) Z. Liu et al.   CLINICAL CANCER RESEARCH

Small GTPase RBJ Mediates Nuclear Entrapment of MEK1/MEK2 in Tumor Progression

(2014) Taoyong Chen et al.   CANCER CELL

Progastrin a new pro-angiogenic factor in colorectal cancer

(2014) S Najib et al.   ONCOGENE

Cancer statistics, 2013

(2013) Rebecca Siegel et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Novel Mechanism of MDA-7/IL-24 Cancer-Specific Apoptosis through SARI Induction

(2013) Rupesh Dash et al.   CANCER RESEARCH

Temporal and Pharmacological Characterization of Angiostatin Release and Generation by Human Platelets: Implications for Endothelial Cell Migration

(2013) Aneta Radziwon-Balicka et al.   PLoS One

Ceruloplasmin alters intracellular iron regulated proteins and pathways: Ferritin, transferrin receptor, glutamate and hypoxia-inducible factor-1α

(2012) J. Harned et al.   EXPERIMENTAL EYE RESEARCH

Adjuvant bevacizumab in colon cancer: where did we go wrong?

(2012) Matthew T Seymour   LANCET ONCOLOGY

Bevacizumab plus oxaliplatin-based chemotherapy as adjuvant treatment for colon cancer (AVANT): a phase 3 randomised controlled trial

(2012) Aimery de Gramont et al.   LANCET ONCOLOGY

Soluble Vascular Endothelial Growth Factor Decoy Receptor FP3 Exerts Potent Antiangiogenic Effects

(2012) De-Chao Yu et al.   MOLECULAR THERAPY

The Function of SARI in Modulating Epithelial-Mesenchymal Transition and Lung Adenocarcinoma Metastasis

(2012) Changli Wang et al.   PLoS One

Hallmarks of Cancer: The Next Generation

(2011) Douglas Hanahan et al.   CELL

The transcription factor BATF controls the global regulators of class-switch recombination in both B cells and T cells

(2011) Wataru Ise et al.   NATURE IMMUNOLOGY

Antiangiogenic therapy: impact on invasion, disease progression and metastasis

(2011) John M. L. Ebos et al.   Nature Reviews Clinical Oncology

Plasmid-based STAT3-siRNA efficiently inhibits breast tumor growth and metastasis in mice

(2011) L. DAI et al.   NEOPLASMA

Sunitinib Malate for the Treatment of Pancreatic Neuroendocrine Tumors

(2011) Eric Raymond et al.   NEW ENGLAND JOURNAL OF MEDICINE

Double Antiangiogenic Protein, DAAP, Targeting VEGF-A and Angiopoietins in Tumor Angiogenesis, Metastasis, and Vascular Leakage

(2010) Young Jun Koh et al.   CANCER CELL

Decreased expression of BATF2 is associated with a poor prognosis in hepatocellular carcinoma

(2010) Haiqing Ma et al.   INTERNATIONAL JOURNAL OF CANCER

Collateral damage: toxic effects of targeted antiangiogenic therapies in ovarian cancer

(2010) Rebecca L Stone et al.   LANCET ONCOLOGY

Inhibition of AP-1 by SARI negatively regulates transformation progression mediated by CCN1

(2010) R Dash et al.   ONCOGENE

The Pfam protein families database

(2009) Robert D. Finn et al.   NUCLEIC ACIDS RESEARCH

Cloning and characterization of SARI (suppressor of AP-1, regulated by IFN)

(2008) Z.-z. Su et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Batf3 Deficiency Reveals a Critical Role for CD8 + Dendritic Cells in Cytotoxic T Cell Immunity

(2008) K. Hildner et al.   SCIENCE

Regulation of metastasis in colorectal adenocarcinoma: A collision between development and tumor biology

(2008) J. Joshua Smith et al.   SURGERY

Angiogenesis as a strategic target for ovarian cancer therapy

(2008) Whitney A Spannuth et al.   Nature clinical practice. Oncology